We are live on ! Find out more
CPRX icon

Catalyst Pharmaceutical
CPRX

164 hedge funds and large institutions have $446M invested in Catalyst Pharmaceutical in 2021 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 51 increasing their positions, 60 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,250% more call options, than puts

Call options by funds: $261K | Put options by funds: $6K

154% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 13

29% more capital invested

Capital invested by funds: $345M → $446M (+$101M)

14% more funds holding

Funds holding: 144 → 164 (+20)

0.74% more ownership

Funds ownership: 63.28% → 64.02% (+0.74%)

15% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 60

Holders
164
Holders Change
+20
Holders Change %
+13.89%
% of All Funds
2.52%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
33
Increased
51
Reduced
60
Closed
13
Calls
$261K
Puts
$6K
Net Calls
+$255K
Net Calls Change
+$877K

Top Buyers

1
Two Sigma Investments
Two Sigma Investments
New York
+$4.25M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$3.19M
3
Ameriprise
Ameriprise
Minnesota
+$3.14M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$2.88M
5
Renaissance Technologies
Renaissance Technologies
New York
+$2.44M

Top Sellers

1
LSV Asset Management
LSV Asset Management
Illinois
-$7.94M
2
State Street
State Street
Massachusetts
-$6.7M
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$3.07M
4
AC
Armistice Capital
New York
-$2.81M
5
RA
Royce & Associates
New York
-$2.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
AQR Capital Management
26
AQR Capital Management
Connecticut
$2.97M -$245K -37,244 -8%
Renaissance Technologies
27
Renaissance Technologies
New York
$2.86M +$2.44M +370,648 +710%
Wells Fargo
28
Wells Fargo
California
$2.8M -$2.28M -346,570 -46%
Man Group
29
Man Group
United Kingdom
$2.66M +$572K +87,000 +28%
Aviva
30
Aviva
United Kingdom
$2.61M +$393K +59,700 +18%
QC
31
Quantedge Capital
Singapore
$2.44M +$2.37M +360,100 New
EGI
32
EAM Global Investors
California
$2.35M +$2.29M +347,899 New
Bank of America
33
Bank of America
North Carolina
$2.34M +$1.44M +219,197 +173%
CSS
34
Cubist Systematic Strategies
Connecticut
$2.31M +$1.51M +229,567 +205%
State Board of Administration of Florida Retirement System
35
State Board of Administration of Florida Retirement System
Florida
$2.3M -$365K -55,464 -14%
GC
36
Globeflex Capital
California
$2.06M – – –
UBS Group
37
UBS Group
Switzerland
$1.96M -$1.01M -153,247 -35%
Los Angeles Capital Management
38
Los Angeles Capital Management
California
$1.94M +$367K +55,880 +24%
Fisher Asset Management
39
Fisher Asset Management
Washington
$1.8M +$419K +63,751 +32%
Morgan Stanley
40
Morgan Stanley
New York
$1.79M +$286K +43,508 +20%
PC
41
Prairiewood Capital
North Dakota
$1.77M -$39.7K -6,034 -2%
BGIM
42
Brandywine Global Investment Management
Pennsylvania
$1.72M -$638K -96,975 -28%
EI
43
EAM Investors
California
$1.62M +$1.57M +239,071 New
RJFSA
44
Raymond James Financial Services Advisors
Florida
$1.61M -$9K -1,368 -0.6%
N
45
Natixis
France
$1.6M +$1.55M +236,020 New
Millennium Management
46
Millennium Management
New York
$1.57M +$1.17M +177,246 +327%
Rafferty Asset Management
47
Rafferty Asset Management
New York
$1.55M +$235K +35,802 +19%
American Century Companies
48
American Century Companies
Missouri
$1.49M +$351K +53,383 +32%
Swiss National Bank
49
Swiss National Bank
Switzerland
$1.47M – – –
TCM
50
Tanaka Capital Management
New York
$1.45M +$69.2K +10,530 +5%
1
2
3 4 5

CPRX Hedge Fund Activity: Q4 2021 in Review

164 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Catalyst Pharmaceutical (CPRX) for Q4 2021, worth a combined $446M — up 29% from $345M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new CPRX positions and 13 closed out — a net gain of 20 holders — while 51 added to existing stakes and 60 trimmed.

The largest buyer was Two Sigma Investments, adding an estimated $4.25M. The largest seller was LSV Asset Management, cutting an estimated $7.94M.

  • 164 institutional investors held Catalyst Pharmaceutical (CPRX) as of Q4 2021, up from 144 in Q3 2021.
  • Funds reported $446M of Catalyst Pharmaceutical stock for Q4 2021, up 29% quarter-over-quarter.
  • 33 funds opened new Catalyst Pharmaceutical positions in Q4 2021 and 13 closed out, a net change of +20 holders.
  • The largest Catalyst Pharmaceutical buyer in Q4 2021 was Two Sigma Investments, an estimated $4.25M added.
  • The largest Catalyst Pharmaceutical seller in Q4 2021 was LSV Asset Management, an estimated $7.94M sold.

Based on aggregated 13F filings for Q4 2021.